Drugs / Mulungu
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 1/2 | NCT01948622 Comparator | Jan → Jun 2012 | impacted teeth, multiple | Liane Maciel de Almeida Souza | Completed | No outcome recorded |
| Phase 2/3 | NCT02065843 Comparator | Mar → Apr 2014 | impacted teeth, multiple | Federal University of Sergipe | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mulungu | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02065843 ↗ |
| Known as | Mulungu Matusa, Erytrina mulungu | “Mulungu Matusa, Erytrina mulungu” NCT02065843 ↗ |
| Route | Oral | “received a capsule of 500mg of Mulungu Matusa ® or placebo, orally, one hour before the procedure” NCT01948622 ↗ |